Nanotechnology in Cardiovascular Diseases
Nanomolecular imaging is a new type of imaging with a combination of nanomaterial and molecular biology, using nanoparticles to visualize, characterize, and measure biological processes at molecular and cellular levels in living systems, including radiotracer imaging/nuclear medicine, magnetic resonance (MR) imaging, MR spectroscopy, optical imaging, ultrasound, and other nanomolecular imaging.
Recently, the emergence of nanomolecular imaging has set the stage for an evolutionary leap in the diagnosis and therapeutics of diseases such as cancer and neurological and cardiovascular diseases (CVDs) [1, 2, 3]. CVD is the leading cause of morbidity and mortality in the world. The pathology underpinning CVD is chronic inflammation involving the injury of arterial wall, the infiltration of leukocytes, and the remodeling of vasculature. The main benefits of nanomolecular imaging are derived from the combination of cell type-specific molecular-based, molecular-molecular...
KeywordsAtherosclerotic Plaque Vulnerable Plaque Magnetic Resonance Spectroscopic Imaging Intraplaque Hemorrhage Plaque Disruption
- 17.White, S.J., Sala-Newby, G.B., Newby, A.C.: Overexpression of scavenger receptor LOX-1 in endothelial cells promotes atherogenesis in the ApoE(−/−) mouse model. Cardiovasc. Pathol. 6, 369–373 (2011)Google Scholar